Cause of death, by non-communicable diseases, ages 15-59, female in Iceland
Iceland: Cause of death, by non-communicable diseases, ages 15-59, female was 82.7% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59, female in Iceland, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59, female in Iceland stood at 82.7%.
That represents a change of down 0.8% on the previous year and up 0.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, female in Iceland peaked at 85.3% in 2019 and was at its lowest, 77.8%, in 2000.
That places Iceland 16th out of 185 countries with data for 2021, putting it in the top 10%.
Cause of death, by non-communicable diseases, ages 15-59, female in Iceland, year by year
| Year | % of total female deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 77.8% | — |
| 2010 | 82.3% | +5.7% |
| 2015 | 84.0% | +2.1% |
| 2019 | 85.3% | +1.6% |
| 2020 | 83.4% | -2.3% |
| 2021 | 82.7% | -0.8% |
Iceland compared with similar countries
- Iceland's 82.7% is above the median for high income countries, which is 76.1%, 1.1× the median. (58 countries reporting)
- Iceland's 82.7% is above the median for Europe & Central Asia, which is 73.2%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 77.8% | 77.8% | 77.8% | 1 |
| 2010s | 83.8% | 82.3% | 85.3% | 3 |
| 2020s | 83.1% | 82.7% | 83.4% | 2 |
Countries ranked near Iceland
More health data for Iceland
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2085)
- Heat deaths vs projected death rates, annual growth rate -0.4982 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,358 deaths per 1,000 people (2090)
- Number of infants who die before age 1 0 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.1533 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0283 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1097 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, female in Iceland?
- Cause of death, by non-communicable diseases, ages 15-59, female in Iceland was 82.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, female recorded in Iceland?
- The highest recorded value was 85.3% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, female recorded in Iceland?
- The lowest recorded value was 77.8% in 2000.
- How does Iceland rank for cause of death, by non-communicable diseases, ages 15-59, female?
- Iceland ranks 16th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, female rising or falling in Iceland?
- Over the last ten years it is up 0.6%. The long-run trend across the full record is rising.
- Where does this Iceland data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.